Fulvestrant and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fulvestrant (fulvestrant) and Glipizide (glipizide). Common drug interactions include lactic acidosis among females.

The phase IV clinical study analyzes what interactions people have when they take Fulvestrant and Glipizide. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Fulvestrant?

Fulvestrant has active ingredients of fulvestrant. eHealthMe is studying from 15,769 Fulvestrant users. Check the latest studies of Fulvestrant.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

On Jul, 09, 2026

47 people who take Fulvestrant and Glipizide together, and have interactions are studied.

Fulvestrant and Glipizide drug interactions.

What are the common drug interactions of Fulvestrant and Glipizide, by gender? *:

female:

Lactic acidosis (low ph in body tissues)
Acute respiratory failure
Arrhythmia (irregular heartbeat)
Blood glucose increased
Fatigue (feeling of tiredness)
Gastrointestinal toxicity (damage to digestive tract by any substance)
Leukocytosis (increased white blood cells)
Diarrhoea
Dysgeusia (disorder of the sense of taste)
Electrocardiogram qt prolonged

male:

n/a

What are the common drug interactions of Fulvestrant and Glipizide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Fatigue (feeling of tiredness)
Intervertebral disc protrusion (spinal disc protrusion)
Muscle spasms (muscle contraction)
Pain
Second primary malignancy (after getting cure a cancer, a new cancer development)
Weight increased

50-59:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

60+:

Lactic acidosis (low ph in body tissues)
Acute respiratory failure
Arrhythmia (irregular heartbeat)
Gastrointestinal toxicity (damage to digestive tract by any substance)
Leukocytosis (increased white blood cells)
Dysgeusia (disorder of the sense of taste)
Electrocardiogram qt prolonged
Neoplasm progression (growth of tumour)
Cardiac failure
Metastases to lung (cancer spreads to lung)

What are the existing conditions these people have? *

Type 2 Diabetes: 14 people, 29.79%
Breast Cancer Metastatic: 13 people, 27.66%
Breast Cancer: 13 people, 27.66%
Dyslipidaemia (abnormal amount of lipids): 11 people, 23.40%
Essential Hypertension (primary hypertension): 7 people, 14.89%
Breast Cancer Recurrent: 5 people, 10.64%
High Blood Pressure: 4 people, 8.51%
Nausea And Vomiting: 3 people, 6.38%
Nausea (feeling of having an urge to vomit): 3 people, 6.38%
Breast Cancer Female: 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Fulvestrant and Glipizide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously